
Addus HomeCare (ADUS) Stock Forecast & Price Target
Addus HomeCare (ADUS) Analyst Ratings
Bulls say
Addus HomeCare is well-positioned for growth in the in-home care market as it generates a majority of revenue from the rapidly growing Personal Care segment, and has a strong presence in the hospice and home health segments. However, potential program and policy changes in its revenue sources, such as Medicaid and Medicare, could impact margins and growth. Integration challenges from its recent acquisition of Gentiva and labor constraints in its clinical businesses may also pose risks to achieving its target price. Overall, the company's strong fundamentals and potential for an uptick in acquisition activity make it a solid choice for investors.
Bears say
Addus HomeCare is facing potential headwinds in its personal care segment due to changes in policies and reimbursement rates, which could negatively impact its margins and financial performance. The company's strategy focused on acquisitions, rather than organic growth, also poses integration risks that could affect its future financial projections. Additionally, approximately 20% of the company's revenue comes from its participation in the Illinois CCP, making it vulnerable to any changes in that program.
This aggregate rating is based on analysts' research of Addus HomeCare and is not a guaranteed prediction by Public.com or investment advice.
Addus HomeCare (ADUS) Analyst Forecast & Price Prediction
Start investing in Addus HomeCare (ADUS)
Order type
Buy in
Order amount
Est. shares
0 shares